NCT03076567View on ClinicalTrials.gov

Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach Cancer

CompletedOBSERVATIONAL
Enrollment

440

Participants

Timeline

Start Date

March 9, 2017

Primary Completion Date

February 14, 2020

Study Completion Date

February 21, 2020

Conditions
Stomach CancerGastric Cancer
Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT03076567 - Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach Cancer | Biotech Hunter | Biotech Hunter